# Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

> **NCT06961084** · PHASE2 · RECRUITING · sponsor: **Thomas Hope** · enrollment: 62 (estimated)

## Conditions studied

- Thyroid Cancer

## Interventions

- **DRUG:** Iodine-124
- **PROCEDURE:** Positron Emission Tomography (PET)/Computerized tomography (CT)

## Key facts

- **NCT ID:** NCT06961084
- **Lead sponsor:** Thomas Hope
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-04
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06961084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06961084, "Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06961084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*